Journal of Spectroscopy
Volume 2015 (2015), Article ID 248504, 9 pages
http://dx.doi.org/10.1155/2015/248504

Research Article

A Model System for Concurrent Detection of Antigen and Antibody Based on Immunological Fluorescent Method

Yuan-Cheng Cao1,2

¹Key Laboratory of Optoelectronic Chemical Materials and Devices of Ministry of Education, Jianghan University, Wuhan 430056, China
²Flexible Display Materials and Technology Co-Innovation Centre of Hubei Province, Jianghan University, Wuhan 430056, China

Received 30 January 2015; Revised 8 April 2015; Accepted 15 April 2015

Academic Editor: Rizwan Hasan Khan

Copyright © 2015 Yuan-Cheng Cao. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

This paper describes a combined antigen/antibody immunoassay implemented in a 96-well plate using fluorescent spectroscopic method. First, goat anti-human IgG was used to capture human IgG (model antigen); goat anti-human IgG (Cy3 or FITC) was used to detect the model antigen; a saturating level of model antigen was then added followed by unlabelled goat anti-human IgG (model antibody); finally, Cy3 labelled rabbit anti-goat IgG was used to detect the model antibody. Two approaches were applied to the concomitant assay to analyze the feasibility. The first approach applied FITC and Cy3 when both targets were present at the same time, resulting in 50 ng/mL of the antibody detection limit and 10 ng/mL of antigen detection limit in the quantitative measurements of target concentration, taking the consideration of FRET efficiency of 68% between donor and acceptor. The sequential approach tended to lower the signal/noise (S/N) ratio and the detection of the model antigen (lower than 1 ng/mL) had better sensitivity than the model antibody (lower than 50 ng/mL). This combined antigen/antibody method might be useful for combined detection of antigens and antibodies. It will be helpful to screen for both antigen and antibody particularly in the situations of the multiserotype and high-frequency mutant virus infections.

1. Introduction

Multiplexed detection of antigens in immunoassays has been the most successful strategy using fluorescent probe molecules which are spatially isolated from each other on beads or different locations on a surface [1–3]. Detection schemes for multiple targets have been extensively studied and are commercially available [4–6]. The greatest successes have involved spatially isolated formats such as planar arrays, beads, and separate assays which run concurrently [7–10]. Multiple target assays in a single spatial location or on a single bead are not widely used and the detection using these fluorophores at present is still the challenge due to energy transfer effects. Therefore, the needs to separate spectra and more complex experimental protocols are usually required. Fluorescent methods are widely used in the analysis of immunological assays due to the high sensitivity and simple detection formats [8, 10–16], but multiplexed detection in a spatially homogeneous format has been less successful and faces significant challenges. In particular, when different dyes are used in the system, the energy transfer between the dyes is an inevitable problem leading to variation of fluorescence intensities. Fluorescent dyes based multiplexing detection methods in combined antigen/antibody assays (Ag/Ab) are promising methods permitting simultaneous detection of host antibodies and viral antigens [11–13]. So, a simple and economic way to carry out the combined Ag/Ab assay in one test is of interest.

In order to investigate this possibility, we developed a simple strategy for concurrent detection of antigen and antibody. The strategy involves two applications of a single sample to an immobilized antibody on the well of a 96-well plate. Sample is applied to the immobilized probes and the well is rinsed. Bound antigen is visualized by applying a fluorescent labelled antibody to the antigen.

To subsequently detect the presence of antibodies to the antigen, the plate is then washed with a saturating concentration of antigen. The antigen will bind to the remaining antibody sites on the surface of the plate. The plate is rinsed and a second aliquot of sample is applied. If an antibody is presented in the sample it will bind to the antigen and can be detected by adding a specific antibody to the antigen labelled with a second fluorescent dye. In this study, a model system consisting of human IgG as antigen and anti-human IgG as probe was used as virus antigen and antibody, respectively. By using two kinds of fluorescent labelled antibody and two independent fluorescence detection methods, we demonstrate the detection of Ag/Ab, respectively.

Here we used 96-well plate as platform based on the fluorescent microscope. In this combined Ag/Ab assay strategy showed here, we investigated two approaches to the detection of the two targets. When FITC was used for the first target followed by Cy3 for the second one, the system was proved to be a useful system for the investigations of multitarget detection methods.

2. Materials and Methods

2.1. Reagents

Goat anti-human IgG (I1011, Sigma), human IgG (I2511, Sigma), FITC-labelled goat anti-human IgG (F3512, Sigma), Cy3 labelled goat anti-human IgG (C2571, Sigma), Cy3 labelled rabbit anti-goat IgG (C2821, Sigma), BSA (A3803, Sigma), and PBS (P5368, Sigma) were purchased from Sigma Co. The assay was run in 96-well plastic-bottom COSTAR plate. PBS-T is PBS buffer with 0.05% Tween 20. Other reagents such as Tween 20, NaCl, and HCl were from Sigma in analytical reagent grade and used as received.

2.2. Equipment and Characteristic

The microscope (Olympus IX-71, Japan) was linked with the camera (PCO1600, PCO, GMbH, Germany) and imaging spectroscope (PARISS, LightForm Inc., USA). And mercury lamp was used as the excitation light source (Hg light). The immunoassays were carried out using the 96-well plate with the transparent bottom so that the light can pass through (Figure 1(a)). The excitation light passes through the band-pass (BP) excitation filter and the dichroic mirror (DM) reflects it to the 96-well plate; then the emission light passes through the DM to the long pass (LP) emission filter before the detection of camera and spectroscope. The fluorescent spectra were collected and the intensities were extracted and analyzed in the operation computer. The equipment’s illustration is shown in Figure 1(b). Cy3 labelled IgG was detected with the filter set consisting of a 480–550 nm band-pass (BP) excitation filter, 570 nm dichroic mirror (DM), and 590 nm long pass (LP) emission filter (U-MSWG2; Olympus). Analysis of FITC employed a 470DF35 BP filter, a 515 nm DM, and a 515 LP (IF19-2; Omega).

(a)

(b)

Figure 1: Schematic illumination of antigen and antibody concurrent immunoassay based on the 96-well plate (a) and the fluorescent microscopy based experimental setup (b).

2.3. Antigen/Antibody Detection

The 96-well plate was rinsed several times with low concentration HCl solution and deH₂O and PBS before the loading of probes. In brief, the detection was carried out in the following orders showed in Figure 2:

(1)Goat anti-human IgG (20 μg/mL, in PBS) was loaded at 100 μL/well. The plate was then incubated overnight at 27°C in order to immobilize the IgG. After the immobilization, the wells were blocked with 5% BSA and then washed for several times with PBS-T.(2)50 μL of human IgG (0–20 μg/mL, in PBS) was loaded to the wells. The plate was incubated at 27°C for 4 hours followed by several rinses with PBS-T.(3)Excess Cy3 labelled goat anti-human IgG solution was added to the wells (20 μg/mL, 100 μL/well) and the plate was cultured for 4 hours. The wells were washed with PBS-T, and then the spectra of the wells were taken by the camera and imaging spectrograph.(4)100 μL human IgG (20 μg/mL, in PBS) was added to each well to saturate the unoccupied sites. Then the plate was incubated for 4 hours and rinsed with PBS-T.(5)50 μL of goat anti-human IgG (0–20 μg/mL, in PBS) was loaded to the wells. Then the plate was incubated at 27°C for 4 hours followed by several rinses with PBS-T.(6)Excess Cy3 labelled rabbit anti-human IgG (20 μg/mL, 100 μL/well) was then added to the wells and the plate was incubated at 27°C for 4 hours. The wells then were rinsed with PBS-T several times and the spectra were measured again.

Figure 2: The procedures of this model diagnostic strategy in the immunoassay.

2.4. Methods

Two methods were used to perform the concomitant detection of antibody and antigen (Figure 2). In both cases, the first step was to expose the sample to a surface prepared with a capture reagent for the antigen; this was followed by the detection of the antigen with a labelled antibody. The preparation was then exposed to a saturating level of antigen and washed and analyte sample was added. The preparation was washed again and detected with a labelled specific antibody. In Method 1, the two detection steps were done with two different fluorophores (FITC and Cy3). In Method 2, Cy3 labelled antibody was used for both detection steps.

2.4.1. Method 1

When using Method 1, the analysis of the system is straightforward by detecting the individual fluorescent intensity of FITC and Cy3, except for the rare cases where a disease (such as HCV) is escaping the immune system and hence both antigen and antibodies are present. In this case energy transfer between the two fluorophores results in lower fluorescence from FITC-IgG and sensitized emission of Cy3. In this system, FITC behaves as a donor and Cy3 acts as an acceptor. The effects of energy transfer are presented as energy transfer efficiency () and normalized sensitized emission (SE). is given by

where is the intensity of the donor in the absence of the acceptor and is the intensity of the donor in the presence of the acceptor [14–16]. SE is computed as

where is the intensity of the acceptor in the presence of the donor and is the intensity of the acceptor in the absence of the donor.

2.4.2. Method 2

For Method 2, there are two possibilities at each detection step: presence or absence of the Cy3 fluorescence with the intensity varying with the amount of detected analyte. At the first detection step the Cy3 intensity indicates the concentration of antigen directly. The fluorescence intensity of the second detection step has two parts: (i) antigen detected with Cy3 labelled goat anti-human IgG in the first antigen detection and (ii) antibody detection reporter (Cy3 labeled rabbit anti-goat). Assuming that Cy3 has the same efficiency in both reporters, the increased intensity () between step 1 (I ₁) and step 2 (I ₂) is

indicates the existence of antibody in the sample and the intensity represents the concentration of that antibody (Figure 2). The factor of two arises from the specific design of our model system; however, other designs are possible where this would not be a requirement. Therefore, in this method, only one Cy3 fluorescent signal is employed and the intensities of these two detection steps are collected and calculated to obtain the analyte concentration.

3. Results and Discussion

3.1. Method 1: Detection of Antigen with FITC and Antibody with Cy3

The behaviour of the concomitant assay was investigated by varying the amounts of antigen and antibody which were detected by two different labels (FITC and Cy3, resp.). In this format, quantitative measurements of the individual antigen and antibody signals were complicated by concentration dependent on intensity. The effect of energy transfer on the observed intensities was also investigated by holding the amount of Cy3 constant while varying the amount of FITC and then holding the amount of FITC constant while varying the amount of Cy3 (Figure 3). In the first instance (Figure 3(a)), the concentration of FITC-IgG was increased from 0 to 15.0 μg/mL while maintaining Cy3-IgG at 2 μg/mL. Under these conditions, the Cy3 signal increases by more than a factor of 2 as the result of energy transfer. A similar but opposite effect occurred when the concentration of Cy3-IgG was increased from 0 to 10 μg/mL while the FITC-IgG was held constant; the fluorescent intensity of FITC-IgG decreased by 68% with a standard deviation less than 5% (Figure 3(b)). The background noise in these tests was lower than 1%. These results demonstrated that as the surface coverage of the two labelled antigens increases, the proximity between fluorophores increases which leads to efficient FRET. Therefore, in this system, when the two dyes are applied in the detection, the fluorescent intensity has to be calculated before the concentration-intensity plots.

(a)

(b)

Figure 3: Fluorescence resonance energy transfer when two dyes Cy3-IgG and FITC-IgG were used in this combined Ag/Ab immunoassay system. (a) Cy3 fluorescent intensity differences () when the concentration of FITC-IgG was changed from 0, 1.0, 2.0, 5.0, 7.5, and 10.0 μg/mL. Cy3-IgG was fixed at 2.0 μg/mL. 480–550 nm band-pass excitation filter, 570 nm DM, and 590 nm long pass emission filter sets were used. Exposure time was 600 ms. Other conditions were the same. (b) FITC fluorescent intensity differences () when the concentration of Cy3-IgG was changed from 0, 1.0, 2.0, 5.0, 7.5, and 10.0 μg/mL. 470DF35 excitation filter, 515 nm DM, and 515 LP emission filter sets were used. FITC-IgG was fixed at 2.0 μg/mL. Exposure time was 600 ms. Other conditions were all the same.

3.2. Applications and Limits of Method 1

3.2.1. Applications

In order to analyze the detection possibilities in this model, the detailed strategy was showed in Figure 4. From the above results of the proposed concurrent detection of Ag/Ab assay, it appears that there are five possibilities, which are shown in Table 1. These five possibilities may cover most of the clinical diagnostic scenario based on detection of antigen and/or antibody in the sample. For example, in case 1, the results indicate the existence of an active antigen in the sample; in case 2, the results indicate the coexisting of antigen and antibody, which is rare in practice (as it is not possible that both antigen and antibody exist in the same sample); and, for cases 3 and 4, they indicate the existing of either antigen or antibody, while, in case 5, they mean there is no detectable antigen and antibody in the sample.

Table 1: Five possibilities in this analytical strategy.

Case
Detection 1
Detection 2
Result

1
Positive (saturating)
—
Ag (active infection)

2
Positive
Positive
Ag + Ab (rare)

3
Positive
Negative
Ag (infection)

4
Negative
Positive
Ab (immunity)

5
Negative
Negative
—

Figure 4: The scheme of this model diagnostic strategy and its operation procedures.

3.2.2. Limits and Solutions

Due to the energy transfer, it is impossible to apply standard calibration procedures or use the direct detection method in this system. But it is still possible to obtain the analyte concentration by calibration using (1) and (2) discussed in Section 2.4.1. In order to show the practical solutions for this method, more tests had been carried out.

As antigen was added in a decreased concentration, two types of results were expected: presence or absence of FITC signal, depending on the concentration of the antigen. The absence of FITC signal indicates the absence of any detectable concentration of the antigen and vice versa. Series of antigen (human IgG) concentrations were tested to show the detection limit of this assay (Figure 5(a)). The results clearly showed that, with the increasing of antigen concentration, the fluorescence intensity increases in the range of 0 ng/mL–3.0 μg/mL (linear relation); but when the antigen concentration was increased beyond 1.0 μg/mL, the intensity did not increase corresponding to the concentration. This may be because the antigen in the sample saturates the probes immobilized on the surface of the well when the concentration was higher than 1.0 μg/mL (Figure 5(b)). In this case, it means that the sample contains high concentration of active antigen when the fluorescence intensity was in the scope of nonlinear range (antigen concentration was higher than 1.0 μg/mL).

(a)

(b)

Figure 5: The FITC-labelled anti-human IgG immunoassay and its work curve in this system. (a) Spectra of human IgG in series concentration in the reactions. From curves 1 to 7 the human IgG concentration was 0 ng/mL, 30 ng/mL, 50 ng/mL, 100 ng/mL, 0.2 μg/mL, 0.4 μg/mL, 0.5 μg/mL, 1.0 μg/mL, 1.5 μg/mL, 2.0 μg/mL, and 3.0 μg/mL. (b) The correlation of fluorescent intensity and concentration of human IgG. The data were repeated for 3 times.

From the fluorescent signal, one can see that the lower limit obtained by this method was down to 50 ng/mL (Figure 5(a)). The intensity increases with the increasing of human IgG concentration (antigen in this case) and there was a linear correlation (; ) between the intensity and antigen concentration in the range of 50 ng/mL~1 μg/mL.

Following the antigen detection, antibody detection was carried out by changing the filter for Cy3. The signal of Cy3 indicates the existence of antibody in the sample and intensity represents the concentration of antibody (Figure 6). This was similar to the described antigen detection procedure, where there were two possibilities for the antibody detection: absence or presences of the Cy3 signal after the loading of the samples. The absence of Cy3 fluorescent signal in the detection indicates the absence of any detectable antibody in the sample. Series of human IgG concentrations (modelled as antibody here) from 0 to 3.0 μg/mL was loaded into the wells which were preloaded with anti-human IgG probes. Results (Figures 6(a) and 6(b)) clearly showed that the intensity was linear to the concentration of the target in the range of 10 ng/mL~1.0 μg/mL (, ).

(a)

(b)

Figure 6: The Cy3 labelled antibody immunoassay and its work curve in this system. (a) The concentration of human IgG that was employed to the wells was 0 ng/mL, 10 ng/mL, 50 ng/mL, 100 ng/mL, 0.5 μg/mL, and 1 μg/mL. (b) Work curve of fluorescent intensity and human IgG. The tests were repeated for 3 times.

It should also be noted that energy transfer will only be a problem when both Ab and Ag are present in a sample and at least one of them is present at high concentration. In the absence of these two conditions, the doubly labelled approach will be successful. In the clinical practices, the positive species have either high concentration of antigens with low concentration of antibody or high concentration of antibody with low concentration of antigen. Either case will be in the applicable conditions for this strategy as discussed above.

3.3. Method 2: Detecting Ag and Ab Using a Single Fluorophore and Two Measurements

The behaviour of the model antigen (human IgG) was investigated by varying the concentration in a series from 0 to 20 μg/mL, the intensity in a nearly linear fashion at low concentration followed by saturation (Figure 7(a)), but we can see from Figure 7(b) that the intensity did not increase in ratio to the target concentration after 1.0 μg/mL, which means the amount of antigen in the sample can saturate the probe which was preimmobilized on the wells. And also the results showed that the as-used 96-well plate has very good preference in the low background noise (less than 0.5%). For 96-well plate, the lower detection limit is determined by the signal/noise. Antigen could still be distinguished from background noise down to 30 ng/mL (Figure 7(c)). In theory, the detection limit is lower than 1 ng/mL according to equation (4):

where is Student’s -test (, 99% confidence level) and is standard deviation; is linear slope in Figure 7(c).

(a)

(b)

(c)

Figure 7: The antigen detection fluorescent intensities (a) and the relation between intensities and higher concentrations (b) and lower concentration (c). For (a) and (b) the exposure time was 600 ms and for (c) it was 8000 ms.

After the antigen detection, excess antigen was loaded to the well to saturate the unoccupied probes. In this model system, Cy3 labeled rabbit anti-goat IgG was used as the antibody detection reporter. Antibody was loaded into the wells at concentrations from 50 ng/mL to 20 μg/mL. Results (Figure 8(a)) clearly show that the fluorescent intensity increases according to the antibody concentration. From the results (Figure 8(b)) we can see increased when the antibody concentration was in the range of 50 ng/mL to 1.0 μg/mL in this model system.

(a)

(b)

Figure 8: (a) The fluorescent intensities for the detection of antibody and (b) the relation between intensity and antibody concentration (50 ng/mL, 500 ng/mL, 1 μg/mL, 2.5 μg/mL, 10 μg/mL, and 20 μg/mL); . The exposure time is 600 ms.

3.4. Application of Method 2

In this system, the first detection is aimed at the antigen, which has better sensitivity for low titer of antigen in real samples from clinic diagnostic; and the second is aimed at antibody which usually has higher titer so that it is easier to be detected in detection 2. From the results we show above, it appears that there is a possibility for the combined Ag/Ab immunoassay in one system when only one Cy3 label marked antibody is applied to the test system.

4. Conclusion

In a word, an approach to detect the antigen and antibody concomitantly is demonstrated in this paper. By comparing the relative fluorescent intensity, Method 1 proposed in this paper has better sensitivity in the detection of antigen than in the detection of the antibody, and it is applicable to the clinic species in which usually the antigen concentration is low. But the idea of using one fluorophore both for antigen and for antibody reporter will simplify the detection system. And the one test for both antigen and antibody is also a more economic format for the combination of Ag/Ab immunoassay than most of reported methods which have separate steps to test antigen and antibody. And also five cases were concluded by one fluorophore and two detection strategies in a cheap and simple method. The sensitivity can be comparable to the commercial plate-based methods, and it will be helpful to screen for both antigen and antibody particularly in the situations of the multiserotype and high-frequency mutant virus infections.

Conflict of Interests

The author declares that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The project was sponsored by the Scientific Research Initial funding for the advanced talent of Janghan University (08010001), Hubei Province Innovative Young Research Team in Universities (T201318), Hubei Provincial Key Natural Science Foundations (2014CFA098), and National High Technology Research and Development Program of China (863 Program no. 2015AA033406).

References

N. M. Victor and Y. M. Tamara, “Active bead-linked immunoassay on protein microarrays,” Analytica Chimica Acta, vol. 564, no. 1, pp. 40–52, 2006.

G. Ma, H. Zhang, J. Guo, X. Zeng, X. Hu, and W. Hao, “Assessment of the inhibitory effect of rifampicin on amyloid formation of hen egg white lysozyme: thioflavin T fluorescence assay versus FTIR difference spectroscopy,” Journal of Spectroscopy, vol. 2014, Article ID 285806, 5 pages, 2014.

L. J. Kricka, “Microchips, microarrays, biochips and nanochips: personal laboratories for the 21st century,” Clinica Chimica Acta, vol. 307, no. 1-2, pp. 219–223, 2001.

B. S. Edwards, T. Oprea, E. R. Prossnitz, and L. A. Sklar, “Flow cytometry for high-throughput, high-content screening,” Current Opinion in Chemical Biology, vol. 8, no. 4, pp. 392–398, 2004.

M. Olivier, “The Invader® assay for SNP genotyping,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 573, no. 1-2, pp. 103–110, 2005.

D. A. Khundzhua, S. V. Patsaeva, V. A. Terekhova, and V. I. Yuzhakov, “Spectral characterization of fungal metabolites in aqueous medium with humus substances,” Journal of Spectroscopy, vol. 2013, Article ID 538608, 7 pages, 2013.

D. M. Rissin and D. R. Walt, “Duplexed sandwich immunoassays on a fiber-optic microarray,” Analytica Chimica Acta, vol. 564, no. 1, pp. 34–39, 2006.

S. N. Alvi, M. N. Patel, P. B. Kathiriya, B. A. Patel, and S. J. Parmar, “Simultaneous determination of prasugrel and aspirin by second order and ratio first order derivative ultraviolet spectrophotometry,” Journal of Spectroscopy, vol. 2013, Article ID 705363, 7 pages, 2013.

S.-P. Song, B. Li, J. Hu, and M.-Q. Li, “Simultaneous multianalysis for tumor markers by antibody fragments microarray system,” Analytica Chimica Acta, vol. 510, no. 2, pp. 147–152, 2004.

M. B. Meza, “Bead-based HTS applications in drug discovery,” Drug Discovery Today, vol. 5, no. 1, pp. 38–41, 2000.

D. McElborough, “Importance of using an HIV Ag/Ab combined assay in a UK population at high risk of acquiring HIV infection,” Communicable Disease and Public Health, vol. 7, no. 4, pp. 312–314, 2004.

B. Weber, T. Meier, and G. Enders, “Fourth generation human immunodeficiency virus (HIV) screening assays with an improved sensitivity for p24 antigen close the second diagnostic window in primary HIV infection,” Journal of Clinical Virology, vol. 25, no. 3, pp. 357–359, 2002.

B. Weber, “HIV seroconversion: performance of combined antigen/antibody assays,” AIDS, vol. 17, no. 6, pp. 931–933, 2003.

W. R. Algar and U. J. Krull, “Towards multi-colour strategies for the detection of oligonucleotide hybridization using quantum dots as energy donors in fluorescence resonance energy transfer (FRET),” Analytica Chimica Acta, vol. 581, no. 2, pp. 193–201, 2007.

K. K. Sinha and J. B. Udgaonkar, “Dissecting the non-specific and specific components of the initial folding reaction of barstar by multi-site FRET measurements,” Journal of Molecular Biology, vol. 370, no. 2, pp. 385–405, 2007.

L. Kokko, T. Kokko, T. Lövgren, and T. Soukka, “Particulate and soluble Eu(III)-chelates as donor labels in homogeneous fluorescence resonance energy transfer based immunoassay,” Analytica Chimica Acta, vol. 606, no. 1, pp. 72–79, 2008.